Repetitive Game Testing: 3 Ways AI Liberates Developers | By: David Melhart, Ph.D., AI Researcher at modl.ai

In a recent article in the Harvard Business Review, authors H. James Wilson and Paul R. Daugherty discussed collaborative intelligence for developing employees. They stated, “Humans and machines can enhance each other’s strengths.” In summary, their research concluded the following:

“Artificial intelligence is transforming all sectors of the economy, but there’s no reason to fear that robots will replace all human employees. In fact, companies that automate their operations mainly to cut their workforces will see only short-term productivity gains, say the authors. Their research, involving 1,500 firms in a range of industries, shows that the biggest performance improvements come when humans and smart machines work together, enhancing each other’s strengths.”

As in many industries, the application of AI in game development intends to enhance humans’ strengths by liberating them from repetitive tasks that could be limiting their creativity or ability to apply their knowledge and expertise in other more productive areas. AI enables game developers to cut the time spent in repetitive game testing, for example.

Game testing requires hours and hours of repetitive, very detailed, and thorough testing for the smallest bugs that could break a game. Let’s discuss three ways in which AI can collaborate with game developers in repetitive testing:

  • Continuous testing: AI can provide ongoing testing for games in production, reducing the time it takes to iterate on new features. This can be especially valuable for games following a live-service model, where new features are being developed continuously during the game’s lifetime. Nevertheless, AI testing can reduce the amount of repetitive human testing in any project, freeing up valuable QA and developer time.
  • Exploratory testing: An AI bot can go anywhere a player could possibly think of going to test and provide information on where the issues in the game reside. By being able to sweep through a large amount of content, AI bots can reliably discover crashes, errors, exceptions, and relative performance changes. This can boost the QA workflow by fast-forwarding the discovery of issues, allowing QA testers to focus on investigation.
  • Actionable reporting: An AI-powered system can deliver actionable reports with game logs, video recordings, and AI insights to help analyze, correct, and test potential issues. By providing a breadth of contextual information and actionable insights, these systems can significantly enhance the game development cycle.

In game development, there is nothing like the experience a developer brings to the table. Adding AI to the mix allows developers’ strengths (creativity, critical thinking, leadership, among others) to stand out while the AI collaborates with data. In simple words, it is about letting the AI bot know what you need, running it, reviewing it, fixing it, and repeating it (if necessary).

AI still has a long way to go in game development, but in the meantime, human/AI collaboration is a step forward to continue to create and develop games that people want to play with the quality that the times require.

About the author:

David Melhart is an AI Researcher at modl.ai, focusing on player modeling and affective computing. Melhart earned his Ph.D. at the University of Malta, Institute of Digital Games. While working as an AI Researcher for modl.ai since 2019, David also remains connected to academia. As a Post-Doc and Research-Support Officer at the University of Malta, Institute of Digital Games, David is involved in teaching the next generation of game AI researchers artificial intelligence and affective computing.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Experts Views and Opinions

The creation of CAR T cell therapy begins with collection of the patient’s blood and separation of the lymphocytes. These include T cells, B cells, and innate lymphoid cells, all of which are separated through apheresis (leukapheresis). It is this separation process which, if optimized, has the potential to revolutionize immunotherapy treatments for cancer patients.
The latest results from a clinical trial presented today at the VEITHsymposium in New York City demonstrate how new living blood vessels created through restorative medical devices have become reality and can open unthinkable treatment avenues for patients. Xeltis is developing cardiovascular devices, namely artificial vessels and valves, that gradually create living and long-lasting vessels made of patients’ own, new healthy tissue.
In the dynamic realm of entrepreneurship, where seasoned professionals often take center stage, the story of Sai Mattapalli and Rohan Kalahasty — both 17-year-old high school seniors — emerges as a beacon of inspiration. 
Within two years, the U.S. will have a shortage of 98,700 medical and lab technologists and more than 80% of health systems are currently reporting shortages in their radiology departments. More than half of the radiologists in the U.S. are 55 and older, and the flow of residents to fill the gap isn’t nearly big enough. The staffing shortage is even more acute among radiation technologists and in the U.K., 97% of radiology departments cannot meet diagnostic reporting requirements.
Dr. Litwin advises, "Approximately 60 study sites worldwide are participating in RESPONDER-HF, a randomized clinical trial of the Corvia Atrial Shunt." What to know more about this life-saving device? Read what this expert has to say.

By using this website you agree to accept Medical Device News Magazine Privacy Policy